75F40124C00074
Definitive Contract
Overview
Government Description
THE U.S. FOOD AND DRUG ADMINISTRATION (FDA) HEREBY INTENDS TO PROCURE PROJECT MANAGEMENT SUPPORT SERVICES THROUGH A DIRECT 8(A) AWARD OF A SINGLE, LABOR-HOUR (LH) TYPE CONTRACT CONSISTING OF ONE (1), 12-MONTH BASE PERIOD AND NO OPTION PERIODS.
Awardee
Awarding / Funding Agency
Place of Performance
Silver Spring, MD 20993 United States
Pricing
Labor Hours
Set Aside
8(A) Sole Source (8AN)
Extent Competed
Not Available For Competition
Related Opportunity
75F40124R00093
Analysis Notes
DOGE This definitive contract was on the Department of Government Efficiency (DOGE) termination list as of July 2025. See All
Termination This definitive contract was terminated for convenience (partial or complete) in March 2025.
Amendment Since initial award the Potential Award value has increased 9% from $1,549,009 to $1,686,696.
Sole Source This Definitive Contract was awarded sole source to Kaiva Strategies because the government was authorized to sole source the contract by statute to a certified 8(a) firm for a contract estimated at award to be <$7.0 million.
Undisclosed Subcontractors No subcontract awards have been formally disclosed for this contract; however, based on invoice data these subcontractors have worked on this contract: Kaiva Tech, DRT Strategies
Termination This definitive contract was terminated for convenience (partial or complete) in March 2025.
Amendment Since initial award the Potential Award value has increased 9% from $1,549,009 to $1,686,696.
Sole Source This Definitive Contract was awarded sole source to Kaiva Strategies because the government was authorized to sole source the contract by statute to a certified 8(a) firm for a contract estimated at award to be <$7.0 million.
Undisclosed Subcontractors No subcontract awards have been formally disclosed for this contract; however, based on invoice data these subcontractors have worked on this contract: Kaiva Tech, DRT Strategies
Kaiva Strategies was awarded
Definitive Contract 75F40124C00074 (75F401-24-C-00074)
worth up to $1,686,696
by the FDA Office of Acquisition and Grant Services
in July 2024.
The contract
has a duration of 1 year and
was awarded
with a 8(a) Sole Source set aside
with
NAICS 541611 and
PSC R499
via sole source acquisition procedures with 1 bid received.
Status
(Complete)
Last Modified 4/1/25
Period of Performance
7/24/24
Start Date
7/26/25
Current End Date
7/26/25
Potential End Date
Obligations
$1.7M
Total Obligated
$1.7M
Current Award
$1.7M
Potential Award
Award Hierarchy
Definitive Contract
75F40124C00074
Subcontracts
Activity Timeline
Labor Services Billing
Annual labor billing rates and FTE reported for 75F40124C00074
| Year | Services Invoiced | Hours | FTE | Blended Rate |
|---|---|---|---|---|
| 2024 | $284,886 | 2,333.1 | 1.1 | $122.11 |
Subcontract Awards
Disclosed subcontracts for 75F40124C00074
Transaction History
Modifications to 75F40124C00074
People
Suggested agency contacts for 75F40124C00074
Competition
Number of Bidders
1
Solicitation Procedures
Sole Source
Other Than Full and Open Competition
Authorized By Statute
Evaluated Preference
None
Commercial Item Acquisition
Commercial Item Procedures Not Used
Simplified Procedures for Commercial Items
No
Other Categorizations
Subcontracting Plan
Plan Not Required
Cost Accounting Standards
Exempt
Business Size Determination
Small Business
Awardee UEI
HCWKVFGBPA64
Awardee CAGE
99AZ4
Agency Detail
Awarding Office
75F401 FDA OFFICE OF ACQ GRANT SVCS
Funding Office
75F401
Created By
hhspframe
Last Modified By
hhspframe
Approved By
hhspframe
Legislative
Legislative Mandates
None Applicable
Performance District
MD-08
Senators
Benjamin Cardin
Chris Van Hollen
Chris Van Hollen
Representative
Jamie Raskin
Modified: 4/1/25